MyFinsight
Home
About
Contact
rigl: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, RIGL has $242,534K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
242,534
206,736
Total stockholders' equity
117,609
81,934
Total liabilities and stockholders' equity
242,534
206,736
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid and other
current assets
$18,556K
Inventories
$13,303K
Accounts receivable, net
$45,925K
Short-term investments
$88,609K
Cash and cash
equivalents
$48,534K
Other assets
$1,167K
Operating lease
right-of-use asset
$1,050K
Intangible assets, net
$25,336K
Property and equipment,
net
$54K
Total current assets
$214,927K
Total assets
$242,534K
Total liabilities and
stockholders' equity
$242,534K
Total stockholders'
equity
$117,609K
Total liabilities
$124,925K
Accumulated deficit
-$1,291,106K
Accumulated other
comprehensive income
$96K
Additional paid-in capital
$1,408,601K
Long-term portion of loans
payable, net
$29,969K
Long-term portion of lease
liabilities
$556K
Total current
liabilities
$94,400K
Common stock
$18K
Lease liabilities,
current portion
$594K
Deferred revenue
$1,355K
Other accrued
liabilities
$8,943K
Loans payable, net,
current portion
$29,761K
Revenue reserves and
refund liability
$30,020K
Acquisition-related liabilities
$5,000K
Accrued research and
development
$4,816K
Accrued compensation
$10,065K
Accounts payable
$3,846K
Subscribe for Financial Insights
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)